Skip to main navigation INVESTOR RELATIONS CORPORATE PROFILE Eargo is a medical device company dedicated to improving the quality of life of people with hearing loss. Our innovative product and go-to-market approach address the major challenges of traditional hearing aid adoption, including social stigma, accessibility and cost. We believe our Eargo hearing aids are the first and only virtually invisible, rechargeable, completely-in-canal, FDA regulated, Class I exempt device for the treatment of hearing loss. Our differentiated, consumer-first solution empowers consumers to take control of their hearing. Consumers can purchase online or over the phone and get personalized and convenient consultation and support from licensed hearing professionals via phone, text, email or video chat. The Eargo solution is offered to consumers at approximately half the cost of competing hearing aids purchased through traditional channels in the United States. STOCK INFORMATION NASDAQ GS: EAR $5.67 -0.2 (-3.41%) Data Provided by Refinitiv. Minimum 15 minutes delayed. PRESS RELEASES 22 Nov '21 Eargo Receives Notification from Nasdaq Related to Delayed Quarterly Report on Form 10-Q SAN JOSE, Calif., Nov. 22, 2021 (GLOBE NEWSWIRE) -- Eargo, Inc. (Nasdaq: EAR) (the “Company” or “Eargo”), a medical device company on a mission to improve the quality of life of people with hearing loss, today announced the Company received a letter from The Nasdaq Stock Market LLC (“Nasdaq”) 30 Aug '21 Eargo to Present at the 2021 Virtual Wells Fargo Healthcare Conference SAN JOSE, Calif., Aug. 30, 2021 (GLOBE NEWSWIRE) -- Eargo, Inc. (Nasdaq: EAR), a medical device company on a mission to improve the quality of life for people with hearing loss, today announced it will present at the 2021 Virtual Wells Fargo Healthcare Conference via web cast. 12 Aug '21 Eargo Reports Second Quarter 2021 Financial Results Increases Full Year Net Revenue Guidance to Between $93 Million and $96 Million Second Quarter 2021 Highlights: Net revenues of $22.9 million, up 43.7% year-over-year Gross systems shipped of 12,548, up 38.8% year-over-year Return accrual rate of 24.1%, a 3.0 percentage point improvement 26 Jul '21 Eargo to Report Second Quarter 2021 Financial Results on August 12, 2021 SAN JOSE, Calif., July 26, 2021 (GLOBE NEWSWIRE) -- Eargo, Inc. (Nasdaq: EAR), a medical device company on a mission to improve the quality of life of people with hearing loss, today announced it will release financial results for the second quarter 2021 after market close on August 12, 2021. VIEW ALL NEWS VIEW ALL RELEASES RECENT EVENTS November 9, 2021 2021 Annual Meeting of Stockholders September 9, 2021 at 3:20 PM EDT Eargo, Inc. at the 2021 Wells Fargo Healthcare Conference August 12, 2021 at 4:30 PM EDT Eargo Second Quarter 2021 Earnings Conference Call VIEW ALL EVENTS VIEW ALL EVENTS LATEST PRESENTATIONS Second Quarter 2021 Conference Call Slides First Quarter 2021 Conference Call Slides 10th Annual SVB Leerink Global Healthcare Conference Presentation FEATURED PAGES STOCK INFORMATION INFORMATION REQUEST FINANCIAL INFORMATION FAQ INVESTOR TOOLS PRINT PAGE RSS FEEDS SEARCH REQUEST EMAIL ALERTS © 2021 Eargo, Inc. All rights reserved.